{{Rsnum
|rsid=4938016
|Gene=ANKK1
|Chromosome=11
|position=113399293
|Orientation=plus
|GMAF=0.449
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=ANKK1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 46.0 | 44.4 | 9.5
| HCB | 20.5 | 63.6 | 15.9
| JPT | 27.3 | 40.9 | 31.8
| YRI | 22.6 | 43.5 | 33.9
| ASW | 0.0 | 0.0 | 0.0
| CHB | 20.5 | 63.6 | 15.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21095016
|Title=Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women
}}

{{PMID Auto
|PMID=18698520
|Title=Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study.
|OA=1
}}

{{GET Evidence
|gene=ANKK1
|aa_change=Gly442Arg
|aa_change_short=G442R
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4938016
|overall_frequency_n=6568
|overall_frequency_d=10496
|overall_frequency=0.625762
|n_genomes=38
|n_genomes_annotated=0
|n_haplomes=58
|n_articles=0
|n_articles_annotated=0
|nblosum100=6
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}